Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)

Triple negative breast cancer (TNBC) progresses rapidly but lacks effective targeted therapies. Our previous study showed that downregulating syndecan-binding protein (SDCBP) in TNBC inhibits the proliferation of TNBC cells. Dasatinib is a new small-molecule inhibitor of c-src phosphorylation. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiao-Long, Zhang, Jun, Li, Pei-Ze, Lang, Rong-Gang, Li, Wei-Dong, Sun, Hui, Liu, Fang-Fang, Guo, Xiao-Jing, Gu, Feng, Fu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283743/
https://www.ncbi.nlm.nih.gov/pubmed/28141839
http://dx.doi.org/10.1371/journal.pone.0171169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283743/
https://www.ncbi.nlm.nih.gov/pubmed/28141839
http://dx.doi.org/10.1371/journal.pone.0171169

Ejemplares similares